Brazil: Anvisa Launches Public Consultations on Repackaging and Packaging Reuse for Cosmetics
On 20 January 2026, the Brazilian Health Regulatory Agency (Anvisa) launched two public consultations (No. 1380 and No. 1381) addressing the repackaging and reuse of packaging for personal care products, cosmetics, and perfumes. The consultations set out proposed technical requirements and Good Manufacturing Practices (GMP) applicable to these activities and define the product categories eligible for repackaging and packaging reuse. […]
Indonesia, Philippines, Vietnam and Brazil
Indonesia: Health Supplements 2025 Agenda BPOM (the Indonesian Food and Drug Agency) has published its Regulatory Roadmap for 2025, identifying Health Supplements as a key focus area. Some of the key areas addressed are: • Labelling: companies are required to disclose the source of their […]
Brazil: ANVISA Novel Foods Tool | New Upper Limit for Creatine
ANVISA Free Tool for Novel Foods ANVISA has developed a tool to determine whether a specific ingredient is classified as a Novel Food or New Ingredient. This tool, which is available free of charge, aims to help companies understand whether their ingredients are considered a Novel Food or […]
Brazil: Public Consultation on Ingredient Specs | Ban on Food Supplements with ora-pro-nobis | Safe Use of Erythrosine | Update on Plastic Packaging
Brazil and New Normative of Specifications for Ingredients From May 2nd until June 16th, a public consultation is being held regarding ANVISA’s proposal for a new norm that outlines the specifications for ingredients. This proposal is structured into 4 annexes: • Annex 1 – New Ingredients with […]
Brazil: New normative of specifications for ingredients (new ingredients and novel foods)
Last week, Brazil approved a new Normative Instruction that will regulate petitions in the food sector based on approvals already granted by Equivalent Authorities from Foreign Countries (known as Autoridades Reguladores Estrangeiras Equivalentes – AREEs – in Portuguese). This new norm is a significant step toward streamlining Brazil’s approval system, as it will allow petitions submitted to ANVISA to reference […]
